With 0.51 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.41 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $17.2624 whereas the lowest price it dropped to was $16.72. The 52-week range on SLP shows that it touched its highest point at $49.71 and its lowest point at $16.83 during that stretch. It currently has a 1-year price target of $36.25. With its current market cap of 340.48 million, SLP has annualized dividend of $0.06 while the current yield stands at 0.35%. SLP paid its most recent dividend on 1722211200, while the ex-dividend date for that was 1722211200. Beta for the stock currently stands at 0.90.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SLP was down-trending over the past week, with a drop of -7.59%, but this was down by -48.77% over a month. Three-month performance dropped to -31.51% while six-month performance fell -41.38%. The stock lost -39.30% in the past year, while it has lost -64.84% so far this year. A look at the trailing 12-month EPS for SLP yields 0.36 with Next year EPS estimates of 1.07. For the next quarter, that number is 0.23. This implies an EPS growth rate of 77.90% for this year and 13.31% for next year. EPS is expected to grow by 35.21% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 0.62%.
Float and Shares Shorts:
At present, 20.11 million SLP shares are outstanding with a float of 16.24 million shares on hand for trading. On 2025-05-30, short shares totaled 2.06 million, which was 1025.0 higher than short shares on 1745971200. In addition to Mr. Shawn M. O’Connor as the firm’s Chief Executive Officer, Mr. William Frederick serves as its EVP & CFO.
Institutional Ownership:
Through their ownership of 0.85107005 of SLP’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-02-28, SLP reported revenue of $22432000.0 and operating income of $2712000.0. The EBITDA in the recently reported quarter was $4344000.0 and diluted EPS was $0.15.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SLP since 4 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With SLP analysts setting a high price target of 41.0 and a low target of 28.0, the average target price over the next 12 months is 36.25. Based on these targets, SLP could surge 142.17% to reach the target high and rise by 65.39% to reach the target low. Reaching the average price target will result in a growth of 114.12% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.54756 being high and $0.48532 being low. For SLP, this leads to a yearly average estimate of $0.50868.
